一财记者现场直击第六批高值耗材集采开标，双重复活机制如何生效

Core Insights - The sixth batch of national organized high-value medical consumables centralized procurement was held in Tianjin, with 227 companies submitting bids for 496 products, resulting in 440 products from 202 companies being selected [1][2] Group 1: Procurement Details - The procurement included 12 types of medical consumables, specifically drug-coated balloons and urological intervention products, with a significant focus on mainstream companies to ensure diverse supply [1] - The bidding process lasted 11 hours, concluding with the announcement of selected companies the following day [1][2] - The procurement introduced a "reference price" mechanism to prevent irrational bidding and included multiple revival rules to enhance competition and selection rates [2] Group 2: Clinical Impact - Clinical experts indicated that the selected products will benefit patients undergoing related surgeries, particularly in urology and cardiovascular fields [1][3] - The urological intervention category included various essential products for treating urinary system stones, ensuring comprehensive coverage for surgical needs [3] - The centralized procurement aims to improve patient accessibility to treatments and reduce costs for established products, while also encouraging innovation among medical companies [3]